AWM
SBIO icon

AllSquare Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

AllSquare Wealth Management’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$81.3K Hold
2,092
– – 0.04% 176
2025
Q2 		$62.9K Hold
2,092
– – 0.04% 202
2025
Q1 		$59.7K Hold
2,092
– – 0.04% 196
2024
Q4 		$69.1K Sell
2,092
-150
-7% -$5.66K 0.04% 183
2024
Q3 		$83.7K Sell
2,242
-754
-25% -$27.5K 0.05% 165
2024
Q2 		$101K Hold
2,996
– – 0.06% 142
2024
Q1 		$107K Hold
2,996
– – 0.06% 147
2023
Q4 		$98.7K Sell
2,996
-165
-5% -$4.43K 0.06% 146
2023
Q3 		$86K Hold
3,161
– – 0.06% 152
2023
Q2 		$98.5K Hold
3,161
– – 0.06% 139
2023
Q1 		$85.9K Hold
3,161
– – 0.06% 157
2022
Q4 		$96K Hold
3,161
– – 0.07% 138
2022
Q3 		$95K Hold
3,161
– – 0.07% 126
2022
Q2 		$88K Hold
3,161
– – 0.06% 145
2022
Q1 		$106K Hold
3,161
– – 0.06% 141
2021
Q4 		$134K Hold
3,161
– – 0.08% 120
2021
Q3 		$144K Hold
3,161
– – 0.09% 118
2021
Q2 		$155K Sell
3,161
-575
-15% -$27.5K 0.09% 118
2021
Q1 		$188K Buy
3,736
+415
+12% +$23K 0.12% 98
2020
Q4 		$170K Sell
3,321
-250
-7% -$11.9K 0.11% 96
2020
Q3 		$147K Hold
3,571
– – 0.11% 98
2020
Q2 		$149K Sell
3,571
-500
-12% -$19.7K 0.11% 92
2020
Q1 		$129K Sell
4,071
-620
-13% -$23.7K 0.11% 94
2019
Q4 		$198K Buy
4,691
+660
+16% +$24.5K 0.14% 87
2019
Q3 		$127K Hold
4,031
– – 0.09% 108
2019
Q2 		$146K Sell
4,031
-250
-6% -$8.62K 0.11% 97
2019
Q1 		$155K Buy
4,281
+10
+0.2% +$334 0.12% 93
2018
Q4 		$120K Buy
4,271
+1,485
+53% +$49.2K 0.1% 98
2018
Q3 		$110K Buy
2,786
+1,700
+157% +$64.5K 0.08% 112
2018
Q2 		$40K Hold
1,086
– – 0.03% 199
2018
Q1 		$37K Buy
1,086
+1,015
+1,430% +$35.6K 0.03% 170
2017
Q4 		$2K Hold
71
– – ﹤0.01% 363
2017
Q3 		$2K Hold
71
– – ﹤0.01% 342
2017
Q2 		$2K Hold
71
– – ﹤0.01% 164
2017
Q1 		$2K Buy
+71
New +$1.77K ﹤0.01% 339

Other funds holding SBIO

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

AllSquare Wealth Management's SBIO Position: Q3 2025 in Review

AllSquare Wealth Management held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q3 2025 at 2,092 shares worth $81.3K. The position accounts for 0.04% of the portfolio, ranked #176.

AllSquare Wealth Management first reported a position in SBIO in Q1 2017 and has held it in 35 quarters since. The position peaked at $198K in Q4 2019. 39 funds tracked by Wall St. Rank hold SBIO as of Q3 2025.

  • AllSquare Wealth Management held 2,092 shares of ALPS Medical Breakthroughs ETF worth $81.3K as of Q3 2025.
  • AllSquare Wealth Management left its ALPS Medical Breakthroughs ETF share count unchanged in Q3 2025.
  • ALPS Medical Breakthroughs ETF made up 0.04% of AllSquare Wealth Management's portfolio in Q3 2025, its #176 holding.
  • AllSquare Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q1 2017 and has held it in 35 quarters since.
  • AllSquare Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $198K in Q4 2019.
  • 39 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.